Steglujan® / Merck: I'm the Type

STEGLUJAN, a prescription medicine, was launched in the US to build awareness and trial the medicine among younger, more ethnically diverse Type-2 Diabetes (T2D) sufferers who were busy with a hectic lifestyle.

Summary of the marketing challenge, methodology, insight discovered, creative execution and business impact.

Nearly one in five US adults have Type 2 Diabetes, with age of diagnosis skewing increasingly younger.

The STEGLUJAN I'm the Typecampaign addresses...

WARC subscribers can sign in to keep reading

Not a subscriber?

Schedule your live demo with our team today